In the pathological state of neurodegenerative diseases, the activity of acetyltransferase and deacetylase is unbalanced, resulting in abnormal acetylation modifications of tau proteins, which in turn impairs the function of tau proteins. This evidence concerns the gene MAPT and neurodegenerative disease.